Ubiquitin Thiolesterase 17: Unraveling Its Role in Protein-Protein Interactions and DNA Replication

Target Name: Ubiquitin carboxyl-terminal hydrolase 17-like protein 24

NCBI ID: P14517

Ubiquitin carboxyl-terminal hydrolase 17-like protein 24

Ubiquitin Thiolesterase 17: Unraveling Its Role in Protein-Protein Interactions and DNA Replication

Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 (Ubiquitin thiolesterase 17) is a protein that is expressed in a variety of tissues and cells in the human body. It is a member of the Ubiquitin family of proteins, which are involved in the regulation of protein-protein interactions and DNA replication. Mutations in the Ubiquitin gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Ubiquitin thiolesterase 17 is a protein that is expressed in many different tissues and cells in the human body. It is found in the cytoplasm of eukaryotic cells and in the nucleus of prokaryotic cells. It is involved in the detoxification of Ubiquitin, a protein that is involved in the regulation of protein-protein interactions and DNA replication. Ubiquitin thiolesterase 17 is thought to play a role in the degradation of Ubiquitin, which is a protein that is involved in the regulation of cell division and the development of tissues.

One of the functions of Ubiquitin thiolesterase 17 is to protect Ubiquitin from attack by other proteins. Ubiquitin is a large protein that is involved in the regulation of protein-protein interactions and DNA replication. It is made up of several domains, including a carboxyl-terminal domain that is involved in the detoxification of Ubiquitin. Ubiquitin thiolesterase 17 is thought to be involved in the protection of Ubiquitin from attack by other proteins.

Another function of Ubiquitin thiolesterase 17 is to regulate the levels of Ubiquitin in the cell. Ubiquitin is a protein that is involved in the regulation of cell division and the development of tissues. It is made up of several domains, including a carboxyl-terminal domain that is involved in the detoxification of Ubiquitin. Ubiquitin thiolesterase 17 is thought to be involved in the regulation of the levels of Ubiquitin in the cell.

In addition to its role in the regulation of Ubiquitin, Ubiquitin thiolesterase 17 is also thought to be involved in the regulation of other proteins. For example, it is known to be involved in the regulation of the levels of the protein known as p21, which is a protein that is involved in the regulation of cell division. It is also thought to be involved in the regulation of the levels of the protein known as p53, which is a protein that is involved in the regulation of DNA replication.

Despite its importance in the regulation of a variety of proteins, Ubiquitin thiolesterase 17 is not well understood. There are currently no drugs that are specifically designed to target Ubiquitin thiolesterase 17. This suggests that it may be an attractive target for future research and development.

In conclusion, Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 (Ubiquitin thiolesterase 17) is a protein that is expressed in a variety of tissues and cells in the human body. It is a member of the Ubiquitin family of proteins, which are involved in the regulation of protein-protein interactions and DNA replication. Mutations in the Ubiquitin gene have been linked to a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Ubiquitin thiolesterase 17 is thought to play a role in the detoxification of Ubiquitin and in regulating the levels of Ubiquitin in the cell. Further research is needed to understand its full function and potential as a drug target or biomarker.

Protein Name: Ubiquitin Carboxyl-terminal Hydrolase 17-like Protein 24

The "Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Ubiquitin carboxyl-terminal hydrolase 17-like protein 24 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets